Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2024

Open Access 01-12-2024 | Research

Causes and consequences of quack medicine in health care: a scoping review of global experience

Authors: Ali Amir-Azodi, Mohammad Setayesh, Mohammad Bazyar, Mina Ansari, Vahid Yazdi-Feyzabadi

Published in: BMC Health Services Research | Issue 1/2024

Login to get access

Abstract

Background

The field of health has been facing challenges with fraudulent practices and the prevalence of “quack medicine”. Many cases have given rise to this issue. Therefore, this study aims to comprehensively investigate and categorize the causes and consequences of quack medicine in the healthcare.

Methods

A scoping review, using the 5 stages of Arksey and O’Malley’s framework, was conducted to retrieve and analyze the literature. International databases including the PubMed, Scopus, Embase and Web of Science and also national Iranian databases were searched to find peer reviewed published literature in English and Persian languages. Grey literature was also included. Meta-Synthesis was applied to analyze the findings through an inductive approach.

Results

Out of 3794 initially identified studies, 30 were selected for this study. Based on the findings of this research, the causes of quackery in the health were divided into six categories: political, economic, socio-cultural, technical-organizational, legal and psychological. Additionally, the consequences of this issue were classified into three categories: health, economic and social. Economic and social factors were found to have a more significant impact on the prevalence of quackery in the health sector. Legal and technical-organizational factors played a crucial role in facilitating fraudulent practices, resulting in severe health consequences.

Conclusion

It is evident that governing bodies and health systems must prioritize addressing economic and social factors in combating quackery in the health sector. Special attention should be paid to the issue of cultural development and community education to strengthen the mechanisms that lead to the society access to standard affordable services. Efforts should be made also to improve the efficiency of legislation, implementation and evaluation systems to effectively tackle this issue.
Appendix
Available only for authorised users
Literature
1.
Joodaki H, Rashidian A. Review of corruption in the health Sector: theory, methods and interventions. Hospital. 2010;8(3):82–100.
2.
Imran G, Tanu K. Why quacks thrive!‖. The Hindu. Volume 4. Bangalore; December. 2012.
3.
Hammerschmidt DE. About the cover illustration: the quack doctor. J Lab Clin Med. 2005;146(6):352–3.CrossRefPubMed
4.
Sudhinaraset M, Ingram M, Lofthouse HK, Montagu D. What is the role of informal healthcare providers in developing countries? A systematic review. PLoS ONE. 2013;8(2):e54978.CrossRefPubMedPubMedCentral
5.
6.
Ahmad S, Chaudary A, Shukla AK. A Burning Threat to Human’s Health from Quackery: A Review Study. Int J Contemp Pathol. 2017;3(1).
7.
Dietz J, Gamble WB, Marchlowska J, Wheeler BT. Fighting health care Fraud in bold and innovative ways. Mil Med. 2013;178(10):1041–3.CrossRefPubMed
8.
Kao A. Medical quackery: the pseudo-science of Health and Well-Being. AMA J Ethics. 2000;2(4):30–1.
9.
10.
Edwards IR. Fraudulent and substandard medicines: getting away with Murder? Drug Saf. 2011;34(6):445–8.CrossRefPubMed
11.
12.
McPake B, Asiimwe D, Mwesigye F, Ofumbi M, Ortenblad L, Streefland P, et al. Informal economic activities of public health workers in Uganda: implications for quality and accessibility of care. Soc Sci Med. 1999;49(7):849–65.CrossRefPubMed
13.
Gupta S, Davoodi H, Tiongson E. Corruption and the provision of health care and education services. The political economy of corruption: Routledge; 2001. pp. 123–53.
14.
Lewis M. Governance and corruption in public health care systems. Center for Global Development working paper. 2006(78).
15.
Arora T, Sharma S. Global scenario of counterfeit antimalarials: a potential threat. J Vector Borne Dis. 2019;56(4):288–94.CrossRefPubMed
16.
Bernard VW. Why people become the victims of Medical Quackery. Am J Public Health Nation’s Health. 1965;55:1142–7.CrossRef
17.
18.
Munn Z, Peters MD, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18:1–7.CrossRef
19.
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.CrossRef
20.
Shrivastava SRBL, Shrivastava PS, Ramasamy J. Public health measures to fight counterfeit medicine market. Int J Prev Med. 2014;5(3):370–1.PubMedPubMedCentral
21.
Jarvis WT, Quackery. The national council against health Fraud perspective. Rheumatic Disease Clinics of North America. 1999;25(4):805–14.CrossRefPubMed
22.
23.
24.
25.
Miller A. Exposing medical Fraud: one of the last taboos in society. CMAJ: Can Med Association J = J de l’Association medicale canadienne. 2013;185(1):16–7.CrossRef
26.
Stelfox HT, Redelmeier DA. An analysis of one potential form of health care Fraud in Canada. CMAJ. 2003;169(2):118–9.PubMedPubMedCentral
27.
28.
29.
Iroegbulem VC. Disease Mongering: How Sickness Sells. 2020.
30.
Cowart VS. Health Fraud’s toll: lost hopes, misspent billions. JAMA: The Journal of the American Medical Association. 1988;259(22):3229–30.CrossRefPubMed
31.
Johnson GC, Gottesman RA. The health Fraud battle. Education is the best defense. Postgrad Med. 1989;85(8):289–90.CrossRefPubMed
32.
Hosseini SAR, Darbooy S, Tehrani Banihashemi SA, Naseri SM, Dinarvand R. Counterfeit medicines: report of a cross-sectional retrospective study in Iran. Public Health. 2011;125(3):165–71.CrossRefPubMed
33.
McCullough RR, Bosler B. An interview with Deputy Chief, Health Care Fraud Unit at the U.S. Attorney’s Office. Home Healthc now. 2015;33(10):560–2.CrossRefPubMed
34.
35.
Lohsiriwat V, Lohsiriwat S. Fraud and deceit in published medical research. J Med Association Thail = Chotmaihet Thangphaet. 2007;90(10):2238–43.
36.
Sparrow MK. Health care Fraud control: understanding the challenge. Journal of insurance medicine. (New York NY). 1996;28(2):86–96.
37.
Jarvis W. Quackery: a national scandal. Clin Chem. 1992;38(8B Pt):1574–86.PubMed
38.
Worrall RS. Detecting health Fraud in the field of learning disabilities. J Learn Disabil. 1990;23(4):207–12.CrossRefPubMed
39.
Akunyili DN, Nnani IPC. Risk of medicines: counterfeit Drugs. Int J Risk Saf Med. 2004;16(3):181–90.
40.
41.
Nsimba SE. Problems associated with substandard and counterfeit Drugs in developing countries: a review article on global implications of counterfeit Drugs in the era of antiretroviral (ARVs) Drugs in a Free Market economy. East Afr J Public Health. 2008;5(3):205–10.PubMed
42.
43.
Berthelot J-M, Nizard J, Maugars Y. The negative Hawthorne effect: explaining pain overexpression. Joint Bone Spine. 2019;86(4):445–9.CrossRefPubMed
44.
Price M, Norris DM. Health care Fraud: Physicians as white collar criminals? J Am Acad Psychiatry Law. 2009;37(3):286–9.PubMed
45.
Miller A. Medical fraud north of the 49th. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. 2013;185(1):E31–3.
46.
47.
48.
Widder RM, Anderson DC. The appeal of medical quackery: a rhetorical analysis. Res Social Administrative Pharmacy: RSAP. 2015;11(2):288–96.CrossRef
49.
Pormann PE. The physician and the other: images of the charlatan in medieval Islam. Bull Hist Med. 2005:189–227.
50.
51.
Andriote J. Legal Drug Pushing: How Disease Mongers Keep Us All Doped Up. Essay The Atlantic. 2012.
52.
Stowell NF, Schmidt M, Wadlinger N. Healthcare Fraud under the microscope: improving its prevention. J Financial Crime. 2018.
53.
Shao J, Zhang Q, Ren Y, Li X, Lin T. Why are older adults victims of Fraud? Current knowledge and prospects regarding older adults’ vulnerability to Fraud. J Elder Abuse Negl. 2019;31(3):225–43.CrossRefPubMed
54.
Kovacs S, Hawes SE, Maley SN, Mosites E, Wong L, Stergachis A. Technologies for detecting falsified and substandard Drugs in low and middle-income countries. PLoS ONE. 2014;9(3):e90601.CrossRefPubMedPubMedCentral
55.
Wertheimer AI, Chaney NM, Santella T. Counterfeit pharmaceuticals: current status and future projections. J Am Pharmacists Association: JAPhA. 2003;43(6):710–7. quiz 7–8.CrossRef
56.
Li P, Yang Z. Accounting Fraud and prevention in listed companies in China. Int J Front Sociol. 2019;1(1).
57.
Thahab FAAA. Legal measures to curb fraudulent online pharmacies in COVID-19 period. Int Res J Eng Technol (IRJET). 2020.
58.
Alshahrani W, Alshahrani R, editors. Assessment of blockchain technology application in the improvement of pharmaceutical industry. 2021 international conference of women in data science At Taif University (WiDSTaif); 2021: IEEE.
59.
Nicholas LH, Hanson C, Segal JB, Eisenberg MD. Association between treatment by Fraud and abuse perpetrators and health outcomes among Medicare beneficiaries. JAMA Intern Med. 2020;180(1):62–9.CrossRefPubMed
Metadata
Title
Causes and consequences of quack medicine in health care: a scoping review of global experience
Authors
Ali Amir-Azodi
Mohammad Setayesh
Mohammad Bazyar
Mina Ansari
Vahid Yazdi-Feyzabadi
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2024
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-023-10520-9

Other articles of this Issue 1/2024

BMC Health Services Research 1/2024 Go to the issue

Correction

Correction: Trajectories of primary health care utilization: a 10-year follow-up after the Swedish Patient Choice Reform of primary health care

Research

An exploration of relocation initiatives deployed within and between nursing homes: a qualitative study

Research

Indian Model of Integrated Healthcare (IMIH): a conceptual framework for a coordinated referral system in resource-constrained settings

Research

Postpartum length of hospital stay among obstetric patients in Ibadan, Nigeria

Research

How external and agency characteristics are related to coordination in homecare – findings of the national multicenter, cross-sectional SPOTnat study

Research

Are recent health, welfare and care graduates part of a rural and remote workforce solution? Evidence from Tasmania, Australia